Showing 1631-1640 of 1735 results for "".
- Topcon Announces the US Launch of Aladdin-Mhttps://modernod.com/news/topcon-announces-the-us-launch-of-aladdin-m/2478217/Topcon Healthcare announced that it has launched its new Aladdin-M instrument in the US market. Aladdin-M combines corneal topography, pupillometry, and optical biometry to enable objective measurement of corneal curvature, pupil dynamics, and axial length metrics. The all-in-one Aladdin-M
- Safer and More Effective Glaucoma Surgical Options Will Drive Surgery Device Treatment Penetration Over Next Five Yearshttps://modernod.com/news/safer-and-more-effective-glaucoma-surgical-options-will-drive-surgery-device-treatment-penetration-over-next-five-years/2478181/Expanding use of surgical devices in patients with all stages of glaucoma will increase the role of surgery in the glaucoma treatment paradigm over the next 5 years, according to a Market Scope report. There are four FDA-approved minimally invasive glaucoma surgery (MIGS) stents in the US:
- Sanofi Enters $3.7-Billion Deal to Buy Principia Biopharmahttps://modernod.com/news/sanofi-enters-3-7-billion-deal-to-buy-principia-biopharma/2478166/Sanofi announced Monday a definitive agreement to acquire all of Principia Biopharma’s outstanding stock for $100 per share in cash, representing an equity value of around $3.7 billion, boosting the French drugmaker’s core research areas of autoimmune and allergic diseases. The deal,
- National Vision Announces Special Cash Bonus to Front-Line Associates and Doctorshttps://modernod.com/news/national-vision-announces-special-cash-bonus-to-front-line-associates-and-doctors/2478032/National Vision Holdings announced plans to grant a special cash bonus to front-line associates and doctors. A one-time $250 bonus will be given to all patient-facing and customer-facing associates and the company’s network of doctors in recognition of their hard work and dedication toward
- Women in Ophthalmology (WIO) 2020 Summer Symposium Goes Virtualhttps://modernod.com/news/women-in-ophthalmology-wio-2020-summer-symposium-goes-virtual/2477999/Due to the recent rise in COVID-19 cases in Florida, Women in Ophthalmology (WIO) has decided to is move its Summer Symposium to an all-virtual platform on August 21-23, 2020. “In classic WIO fashion, we have planned an innovative meeting like no other with 24 hours of CME, scientifi
- Topcon Announces the European Launch of MYAH Management Tool for Myopia and Dry Eyehttps://modernod.com/news/topcon-announces-the-european-launch-of-myah-management-tool-for-myopia-and-dry-eye/2477931/Topcon announced it has launched its new MYAH instrument in Europe. MYAH is a management tool for eye care professionals interested in building, managing and growing myopia and dry eye services within their practice or research institution, according to a company news release. The all-in-o
- Politics Around Hydroxychloroquine Hamper Sciencehttps://modernod.com/news/politics-around-hydroxychloroquine-hamper-science/2477807/Publicity around the drug hydroxychloroquine spiked this week when President Donald Trump revealed that he’s taking it to prevent COVID-19. All the attention on the drug in recent months is increasingly spilling into science, and making it harder for some researchers to actually study wheth
- Early Data Show Moderna’s COVID-19 Vaccine Generates Immune Responseshttps://modernod.com/news/first-covid-19-vaccine-tested-in-the-us-shows-promise-in-data-from-eight-people/2477791/Moderna reported positive interim data from a phase 1 study of its vaccine candidate against SARS-CoV-2, with results showing that mRNA-1273 elicited neutralizing antibody titer levels in all eight initial participants in the low- and mid-dose cohorts, reaching or exceeding levels generally seen
- Gilead Inks Non-US Deals With Five Generic Drugmakers to Expand Supply of COVID-19 Drug Remdesivirhttps://modernod.com/news/gilead-inks-non-us-deals-with-five-generic-drugmakers-to-expand-supply-of-covid-19-drug-remdesivir/2477757/Gilead Sciences said it has signed non-exclusive voluntary licensing agreements with Cipla, Ferozsons Laboratories, Hetero Labs, Jubilant Lifesciences and Mylan to manufacture COVID-19 treatment remdesivir for distribution in 127 countries. According to Gilead, the list consists of nearly all low
- AbbVie Completes Acquisition of Allerganhttps://modernod.com/news/abbvie-completes-acquisition-of-allergan/2477739/AbbVie announced that it has completed its acquisition of Allergan after receiving regulatory approval from all government authorities required by the transaction agreement and approval by the Irish High Court. “We are pleased to reach this important milestone for the company, its em